Search results

Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

Latest information on the scheduled supply of our nuclear medicine production.

ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste. 

The Australian Government’s nuclear agency, ANSTO, together with NSW Police and multiple state and federal authorities, has completed an operation to repatriate radioactive waste from the UK.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

ANSTO Synroc technology provides a safe, secure matrix for the immobilisation and final disposal of radioactive waste.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Update on Nuclear medicine production at ANSTO.

The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.

A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula. 

Commitment to undertake health research.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.